Notification report

Full notification file

General information

Notification Number

Member State to which the notification was sent

Date of acknowledgement from the Member State Competent Authority

Title of the Project
Vaccination with naked DNA, encoding the xenogenetic human tyrosinase for the induction of specific defence against melanoma cells in dog

Proposed period of release:
01/01/2011 to 31/12/2015

Name of the Institute(s) or Company(ies)
Utrecht University, Faculty of Veterinary Medicine
Dep. Clinical Sciences of Companion
Yalelaan 108
3584 CM Utrecht,
PO Box 80.154
3508 TD Utrecht
The Netherlands;

3. Is the same GMO release planned elsewhere in the Community?

Has the same GMO been notified elsewhere by the same notifier?

GMO characterization

GMO is a:
Other: The medicinal product is not a GMO.

Identity of the GMO:
The medicinal product is not a GMO. The investigational gene therapy medicinal
product is a plasmid, pING/Tyrosinase. It is a closed circular DNA molecule, without
the properties of a living organism or virus.
The plasmid DNA does not have a taxonomic classification.

Information relating to the recipient or parental organisms from wich the GMO is derived
Common NameGenusSpeciesSubspeciesStrainPathovar

European Commission administrative information

Consent given by the Member State Competent Authority:
Not known